Doron Levin

1.2k total citations
9 papers, 520 citations indexed

About

Doron Levin is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Doron Levin has authored 9 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Doron Levin's work include Cytokine Signaling Pathways and Interactions (4 papers), interferon and immune responses (3 papers) and RNA modifications and cancer (2 papers). Doron Levin is often cited by papers focused on Cytokine Signaling Pathways and Interactions (4 papers), interferon and immune responses (3 papers) and RNA modifications and cancer (2 papers). Doron Levin collaborates with scholars based in Israel, United States and Switzerland. Doron Levin's co-authors include Gideon Schreiber, Daniel Harari, Ganit Yarden, Peter O. Krutzik, Jacob Piehler, Ignacio Moraga, Jeffrey S. Glenn, Choongho Lee, Garry P. Nolan and Christoph Thomas and has published in prestigious journals such as Cell, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Doron Levin

9 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doron Levin Israel 7 347 246 142 69 50 9 520
Ganit Yarden Israel 6 278 0.8× 189 0.8× 114 0.8× 58 0.8× 47 0.9× 7 440
Eyal Kalie Israel 6 268 0.8× 184 0.7× 137 1.0× 67 1.0× 57 1.1× 6 430
Vadim I. Nazarov Russia 6 447 1.3× 177 0.7× 208 1.5× 49 0.7× 64 1.3× 9 679
Ursula Garrigues United States 9 289 0.8× 166 0.7× 217 1.5× 238 3.4× 55 1.1× 9 584
Jim Freeth United States 9 213 0.6× 99 0.4× 170 1.2× 69 1.0× 33 0.7× 10 606
Meriem Attaf United Kingdom 12 584 1.7× 290 1.2× 270 1.9× 90 1.3× 96 1.9× 16 787
Brandi C. Jones United States 9 445 1.3× 204 0.8× 86 0.6× 55 0.8× 140 2.8× 10 617
Pheh-Ping Chang Australia 7 572 1.6× 124 0.5× 138 1.0× 34 0.5× 43 0.9× 8 706
Catherine A. Rumbley United States 13 332 1.0× 88 0.4× 127 0.9× 125 1.8× 30 0.6× 17 569
Mirela Kuka Italy 14 361 1.0× 96 0.4× 127 0.9× 14 0.2× 65 1.3× 26 561

Countries citing papers authored by Doron Levin

Since Specialization
Citations

This map shows the geographic impact of Doron Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doron Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doron Levin more than expected).

Fields of papers citing papers by Doron Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doron Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doron Levin. The network helps show where Doron Levin may publish in the future.

Co-authorship network of co-authors of Doron Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Doron Levin. A scholar is included among the top collaborators of Doron Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doron Levin. Doron Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Levin, Doron & Tamir Tuller. (2020). Whole cell biophysical modeling of codon-tRNA competition reveals novel insights related to translation dynamics. PLoS Computational Biology. 16(7). e1008038–e1008038. 11 indexed citations
2.
Pan, Xiaoyu, Eran Ophir, Zoya Alteber, et al.. (2019). Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity. Cancer Immunology Research. 7(2). 244–256. 45 indexed citations
3.
Levin, Doron & Tamir Tuller. (2018). Genome-Scale Analysis of Perturbations in Translation Elongation Based on a Computational Model. Scientific Reports. 8(1). 16191–16191. 4 indexed citations
4.
Liang, Spencer C., Ofer Levy, Sudipto Ganguly, et al.. (2017). Discovery of COM701, a therapeutic antibody targeting the novel immune checkpoint PVRIG, for the treatment of cancer.. Journal of Clinical Oncology. 35(15_suppl). 3074–3074. 5 indexed citations
5.
Levin, Doron, et al.. (2015). Fine Tuning of a Type 1 Interferon Antagonist. PLoS ONE. 10(7). e0130797–e0130797. 7 indexed citations
6.
Levin, Doron, William M. Schneider, Hans-Heinrich Hoffmann, et al.. (2014). Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist. Science Signaling. 7(327). ra50–ra50. 83 indexed citations
7.
Levin, Doron, Daniel Harari, & Gideon Schreiber. (2011). Stochastic Receptor Expression Determines Cell Fate upon Interferon Treatment. Molecular and Cellular Biology. 31(16). 3252–3266. 84 indexed citations
8.
Thomas, Christoph, Ignacio Moraga, Doron Levin, et al.. (2011). Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons. Cell. 146(4). 621–632. 264 indexed citations
9.
Weiss, Celeste, et al.. (2011). Chloroplast β chaperonins from A. thaliana function with endogenous cpn10 homologs in vitro. Plant Molecular Biology. 77(1-2). 105–115. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026